MedTrace Logo

Effects of Vitamin D Supplementation on Antimycobacterial Immunity

NCT00157066 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 230

Last updated 2007-01-08

No results posted yet for this study

Summary

The purpose of this study is to determine how vitamin D supplementation (ergocalciferol) affects the immune response to mycobacterial infection.

Conditions

Interventions

DRUG

Ergocalciferol

Sponsors & Collaborators

  • Imperial College London

    collaborator OTHER

  • University of Cape Town

    collaborator OTHER

  • Newham Chest Clinic, London E7 8QP, UK

    collaborator UNKNOWN

  • Northwick Park Hospital, Harrow, UK

    collaborator OTHER

  • Department of Clinical Biochemistry, Homerton Hospital, London E9 6SR, UK

    collaborator OTHER

  • Environmental Health Department, London Borough of Newham, London E15 4SF, UK

    collaborator UNKNOWN

  • Wellcome Trust

    collaborator OTHER

  • Barts & The London NHS Trust

    lead OTHER

Principal Investigators

  • Adrian R Martineau, B Med Sci, MBBS, DTM&H, MRCP · Centre for Health Sciences, Barts and The London, QMUL

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-12-31
Completion
2006-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00157066 on ClinicalTrials.gov